BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 37434245)

  • 21. Loss of heterozygosity in the retinoblastoma tumor suppressor gene in skull base chordomas and chondrosarcomas.
    Eisenberg MB; Woloschak M; Sen C; Wolfe D
    Surg Neurol; 1997 Feb; 47(2):156-60; discussion 160-1. PubMed ID: 9040820
    [TBL] [Abstract][Full Text] [Related]  

  • 22. MGMT promoter methylation status in clival chordoma.
    Marucci G; Morandi L; Mazzatenta D; Frank G; Pasquini E; Foschini MP
    J Neurooncol; 2014 Jun; 118(2):271-276. PubMed ID: 24771251
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Genome-wide methylation profiling identified novel differentially hypermethylated biomarker MPPED2 in colorectal cancer.
    Gu S; Lin S; Ye D; Qian S; Jiang D; Zhang X; Li Q; Yang J; Ying X; Li Z; Tang M; Wang J; Jin M; Chen K
    Clin Epigenetics; 2019 Mar; 11(1):41. PubMed ID: 30846004
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Genome-wide DNA methylation profiling identifies epigenetic signatures of gastric cardiac intestinal metaplasia.
    Lin R; Li C; Liu Z; Wu R; Lu J
    J Transl Med; 2020 Jul; 18(1):292. PubMed ID: 32736574
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Chordoma].
    George B; Bresson D; Bouazza S; Froelich S; Mandonnet E; Hamdi S; Orabi M; Polivka M; Cazorla A; Adle-Biassette H; Guichard JP; Duet M; Gayat E; Vallée F; Canova CH; Riet F; Bolle S; Calugaru V; Dendale R; Mazeron JJ; Feuvret L; Boissier E; Vignot S; Puget S; Sainte-Rose C; Beccaria K
    Neurochirurgie; 2014 Jun; 60(3):63-140. PubMed ID: 24856008
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Genome-wide characterization of aberrant DNA methylation patterns and the potential clinical implications in patients with endometrial cancer.
    Wang Y; Liu D; Jin X; Song H; Lou G
    Pathol Res Pract; 2019 Jan; 215(1):137-143. PubMed ID: 30449607
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Hypomethylation coordinates antagonistically with hypermethylation in cancer development: a case study of leukemia.
    Kushwaha G; Dozmorov M; Wren JD; Qiu J; Shi H; Xu D
    Hum Genomics; 2016 Jul; 10 Suppl 2(Suppl 2):18. PubMed ID: 27461342
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Transcriptome comparison identifies potential biomarkers of spine and skull base chordomas.
    Bell AH; DeMonte F; Raza SM; Rhines LD; Tatsui CE; Prieto VG; Fuller GN; Bell D
    Virchows Arch; 2018 Mar; 472(3):489-497. PubMed ID: 28844110
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Genome-wide DNA methylome variation in two genetically distinct chicken lines using MethylC-seq.
    Li J; Li R; Wang Y; Hu X; Zhao Y; Li L; Feng C; Gu X; Liang F; Lamont SJ; Hu S; Zhou H; Li N
    BMC Genomics; 2015 Oct; 16():851. PubMed ID: 26497311
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Unravelling the role of immune cells and FN1 in the recurrence and therapeutic process of skull base chordoma.
    Huo X; Ma S; Wang C; Song L; Yao B; Zhu S; Li P; Wang L; Wu Z; Wang K
    Clin Transl Med; 2023 Oct; 13(10):e1429. PubMed ID: 37784253
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Global DNA methylation profiling reveals new insights into epigenetically deregulated protein coding and long noncoding RNAs in CLL.
    Subhash S; Andersson PO; Kosalai ST; Kanduri C; Kanduri M
    Clin Epigenetics; 2016; 8():106. PubMed ID: 27777635
    [TBL] [Abstract][Full Text] [Related]  

  • 32. HOXA7, HOXA9, and HOXA10 are differentially expressed in clival and sacral chordomas.
    Jäger D; Barth TFE; Brüderlein S; Scheuerle A; Rinner B; von Witzleben A; Lechel A; Meyer P; Mayer-Steinacker R; Baer AV; Schultheiss M; Wirtz CR; Möller P; Mellert K
    Sci Rep; 2017 May; 7(1):2032. PubMed ID: 28515451
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Molecular and clinical risk factors for recurrence of skull base chordomas: gain on chromosome 2p, expression of brachyury, and lack of irradiation negatively correlate with patient prognosis.
    Kitamura Y; Sasaki H; Kimura T; Miwa T; Takahashi S; Kawase T; Yoshida K
    J Neuropathol Exp Neurol; 2013 Sep; 72(9):816-23. PubMed ID: 23965741
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Comprehensive analyses of imprinted differentially methylated regions reveal epigenetic and genetic characteristics in hepatoblastoma.
    Rumbajan JM; Maeda T; Souzaki R; Mitsui K; Higashimoto K; Nakabayashi K; Yatsuki H; Nishioka K; Harada R; Aoki S; Kohashi K; Oda Y; Hata K; Saji T; Taguchi T; Tajiri T; Soejima H; Joh K
    BMC Cancer; 2013 Dec; 13():608. PubMed ID: 24373183
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Recurrent chromosomal copy number alterations in sporadic chordomas.
    Le LP; Nielsen GP; Rosenberg AE; Thomas D; Batten JM; Deshpande V; Schwab J; Duan Z; Xavier RJ; Hornicek FJ; Iafrate AJ
    PLoS One; 2011; 6(5):e18846. PubMed ID: 21602918
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Integrated differential DNA methylation and gene expression of formalin-fixed paraffin-embedded uveal melanoma specimens identifies genes associated with early metastasis and poor prognosis.
    Ness C; Katta K; Garred Ø; Kumar T; Olstad OK; Petrovski G; Moe MC; Noer A
    Exp Eye Res; 2021 Feb; 203():108426. PubMed ID: 33387485
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Epigenetic profiling of cutaneous T-cell lymphoma: promoter hypermethylation of multiple tumor suppressor genes including BCL7a, PTPRG, and p73.
    van Doorn R; Zoutman WH; Dijkman R; de Menezes RX; Commandeur S; Mulder AA; van der Velden PA; Vermeer MH; Willemze R; Yan PS; Huang TH; Tensen CP
    J Clin Oncol; 2005 Jun; 23(17):3886-96. PubMed ID: 15897551
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Evaluation of 1p36 markers and clinical outcome in a skull base chordoma study.
    Longoni M; Orzan F; Stroppi M; Boari N; Mortini P; Riva P
    Neuro Oncol; 2008 Feb; 10(1):52-60. PubMed ID: 18094369
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Genome-wide methylation analysis identifies a core set of hypermethylated genes in CIMP-H colorectal cancer.
    McInnes T; Zou D; Rao DS; Munro FM; Phillips VL; McCall JL; Black MA; Reeve AE; Guilford PJ
    BMC Cancer; 2017 Mar; 17(1):228. PubMed ID: 28351398
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Deep sequencing reveals distinct patterns of DNA methylation in prostate cancer.
    Kim JH; Dhanasekaran SM; Prensner JR; Cao X; Robinson D; Kalyana-Sundaram S; Huang C; Shankar S; Jing X; Iyer M; Hu M; Sam L; Grasso C; Maher CA; Palanisamy N; Mehra R; Kominsky HD; Siddiqui J; Yu J; Qin ZS; Chinnaiyan AM
    Genome Res; 2011 Jul; 21(7):1028-41. PubMed ID: 21724842
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.